Van Well Daan 4
4 · SOPHiA GENETICS SA · Filed May 20, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CLO Daan Van Well Sells 684 Shares
What Happened
Daan Van Well, Chief Legal Officer of SOPHiA GENETICS SA (SOPH), sold 684 shares in an open-market transaction on 2026-05-19 at a weighted average price of $4.60, generating approximately $3,149 in proceeds. The filing notes these sales were made to satisfy tax withholding obligations arising from the vesting of restricted stock units on May 18, 2026, and were executed under a pre-established Rule 10b5-1(c) trading plan (non‑discretionary).
Key Details
- Transaction date: 2026-05-19 (filed 2026-05-20). Filing appears timely (next-business-day).
- Transaction type: Sale to satisfy tax withholding (open market).
- Shares sold: 684; reported proceeds ≈ $3,149.
- Price: weighted average $4.60; shares sold in multiple trades at prices ranging $4.54–$4.66. (Reporting person will provide per‑trade breakdown on written request.)
- Reason/footnotes: F1 — sale to cover tax withholding for RSU vesting (May 18, 2026) under a pre-established 10b5-1 plan; F2 — weighted avg and price range disclosure.
- Shares owned after transaction: Not specified in the provided filing.
Context
These kinds of sales are common when insiders sell shares to cover taxes on vested awards and, when done under a 10b5-1 plan, are pre-planned and non-discretionary. The dollar amount here is small and typically considered routine rather than a directional signal about the company. Purchases by insiders tend to carry more weight for investor sentiment than routine withholding sales.
Insider Transaction Report
- Sale
Ordinary Shares
[F1][F2]2026-05-19$4.60/sh−684$3,149→ 345,052 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on May 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.54 to $4.66, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.